Dorval Allison

CIK 00016251105 companiesLOS ANGELES, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001625110

Recent Transactions

50 trades

Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2026-06-12$7.20/sh−11,610→ 90,780 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2026-06-11+27,000→ 102,390 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−75,000→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Restricted Stock Units
2025-07-25−33,750→ 0 total
Disposition from Tender
Verve Therapeutics, Inc.
Common Stock
2025-07-25−13,280→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Restricted Stock Units
2025-07-25−45,000→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−180,000→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Restricted Stock Units
2025-07-25−1,875→ 0 total
Disposition to Issuer
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-07-25−258,000→ 0 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2025-06-13$3.40/sh−11,610→ 75,390 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2025-06-11+27,000→ 87,000 total
Sale
Verve Therapeutics, Inc.
Common Stock
2025-04-02$4.15/sh−3,350→ 13,280 total
Exercise/Conversion
Verve Therapeutics, Inc.
Restricted Stock Units
2025-04-01−11,250→ 33,750 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2025-04-01+11,250→ 16,630 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-01-08+75,000→ 75,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2025-01-08+258,000→ 258,000 total
Award
Verve Therapeutics, Inc.
Restricted Stock Units
2025-01-08+45,000→ 45,000 total
Sale
Verve Therapeutics, Inc.
Common Stock
2024-12-02$5.64/sh−555→ 5,380 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2024-11-29+1,875→ 5,935 total
Exercise/Conversion
Verve Therapeutics, Inc.
Restricted Stock Units
2024-11-29−1,875→ 1,875 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2024-06-18+27,000→ 60,000 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2024-06-13$3.37/sh−11,000→ 33,000 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2024-06-05+12,500→ 12,500 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2024-02-14+180,000→ 180,000 total
Award
Verve Therapeutics, Inc.
Restricted Stock Units
2024-02-14+45,000→ 45,000 total
Exercise/Conversion
Verve Therapeutics, Inc.
Restricted Stock Units
2023-11-29−1,875→ 3,750 total
Sale
Verve Therapeutics, Inc.
Common Stock
2023-11-29$11.45/sh−554→ 4,060 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2023-11-29+1,875→ 4,614 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2023-06-13+27,000→ 44,000 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2023-06-13$3.45/sh−10,000→ 17,000 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2023-06-06+12,500→ 12,500 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2023-02-14+182,800→ 182,800 total
Sale
Verve Therapeutics, Inc.
Common Stock
2022-11-29$22.10/sh−554→ 2,186 total
Exercise/Conversion
Verve Therapeutics, Inc.
Restricted Stock Units
2022-11-29−1,875→ 5,625 total
Exercise/Conversion
Verve Therapeutics, Inc.
Common Stock
2022-11-29+1,875→ 2,740 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2022-06-21+12,500→ 12,500 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2022-06-14+27,000→ 27,000 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2022-02-11+60,000→ 60,000 total
Award
Verve Therapeutics, Inc.
Restricted Stock Units
2021-11-29+7,500→ 7,500 total
Award
Verve Therapeutics, Inc.
Stock Option (right to buy)
2021-11-29+135,000→ 135,000 total
Award
Jade Biosciences, Inc.$JBIO
Stock Option (Right to Buy)
2021-07-15+25,000→ 25,000 total
Award
PUMA BIOTECHNOLOGY, INC.$PBYI
STOCK OPTION (RIGHT TO BUY)
2021-07-15+108,721→ 108,721 total
Award
Voyager Therapeutics, Inc.$VYGR
Common Stock
2021-03-19+30,000→ 109,894 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2021-02-16+68,000→ 68,000 total
Award
Voyager Therapeutics, Inc.$VYGR
Common Stock
2021-02-16+34,000→ 79,894 total
Sale
Voyager Therapeutics, Inc.$VYGR
Common Stock
2021-02-11$7.55/sh−3,186→ 45,894 total
Sale
Voyager Therapeutics, Inc.$VYGR
Common Stock
2021-01-12$8.62/sh−2,942→ 49,080 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2020-02-10+55,000→ 55,000 total
Award
Voyager Therapeutics, Inc.$VYGR
Common Stock
2020-02-10+27,500→ 52,022 total
Sale
Voyager Therapeutics, Inc.$VYGR
Common Stock
2020-01-21$13.36/sh−3,128→ 24,522 total

Companies

Recent Filings

Address

C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BOULEVARD, SUITE 1700

LOS ANGELES, CA, 90024

View on SEC.gov